Vivos Therapeutics (VVOS) EBITDA Margin Growth (1y) (2021 - 2026)
Powered by 
Analysis
Vivos Therapeutics (VVOS) EBITDA Margin Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Align Technology | 11.30 Bn | 10.20 Bn | 757.43 Mn | -152.00 |
| 2 | Envista Holdings | 4.38 Bn | 3.26 Bn | 407.00 Mn | 420.00 |
| 3 | Dentsply Sirona | 2.27 Bn | 2.03 Bn | 493.00 Mn | 2,281.00 |
| 4 | Milestone Scientific | 37.81 Mn | 35.20 Mn | 1.56 Mn | 5,119.00 |
| 5 | Dror Ortho-Design | 9.77 Mn | 9.68 Mn | - | - |
| 6 | Vivos Therapeutics | 2.76 Mn | 790,007.20 | 2.95 Mn | 3,169.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3,169.00 |
| Mar 31, 2026 | 44.00 |
| Dec 31, 2025 | -9,895.00 |
| Sep 30, 2025 | 204.00 |
| Jun 30, 2025 | -7,421.00 |
| Mar 31, 2025 | -1,550.00 |
| Dec 31, 2024 | 4,792.00 |
| Sep 30, 2024 | 4,131.00 |
| Jun 30, 2024 | 8,481.00 |
| Mar 31, 2024 | 1,680.00 |
| Dec 31, 2023 | 2,481.00 |
| Sep 30, 2023 | 1,539.00 |
| Jun 30, 2023 | 3,156.00 |
| Mar 31, 2023 | 5,212.00 |
| Dec 31, 2022 | 2,049.00 |
| Sep 30, 2022 | -378.00 |
| Jun 30, 2022 | -7,315.00 |
| Mar 31, 2022 | -8,082.00 |
| Dec 31, 2021 | 2,299.00 |
| Sep 30, 2021 | -6,857.00 |